Odyssey Therapeutics, Inc. (ODTX) Insider Trading

7 insiders at Odyssey Therapeutics, Inc. (ODTX) have purchased stock in the past 90 days, totaling $75.3M across 9 transactions (4,183,777 shares).

The most recent purchase was by Director Li Nan (LN) on May 11, 2026 — a $20.0M buy of 1,111,111 shares at $18.00, bringing his total holdings to 3,333,516 shares.

Insiders who purchased: TPG GP A, LLC (Other, 1 buy totaling $25.0M); Li Nan (LN) (Director, 1 buy totaling $20.0M); Dimension Capital II, L.P. (Director, 1 buy totaling $20.0M); SR ONE CAPITAL MANAGEMENT, LLC (10%+ Owner, 3 buys totaling $10.0M); Chu Shelley (Director, 1 buy totaling $200K); LEIDEN JEFFREY M (Director, 1 buy totaling $100K); Haas Jason (CFO, 1 buy totaling $20K).

This insider buying is notable given that ODTX had no recorded open market purchases in the nine months before that.

ODTX is in the Biotechnology sector within the Biotechnology industry with a market cap of $752M.

With 7 different insiders buying in the same 90-day window, this qualifies as cluster buying at ODTX — a pattern that research suggests can signal conviction among management.

Track ODTX insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.